Canada exponentially huge, cash flow positive & growing.
Many are forgetting milestones are being acheived DYOR
The new POs follow the Company’s record revenue growth in Q1 FY2023 (refer ASX announcement: 19 April 2023) of 46% on the last quarter to A$1,547,252 and the group’s maiden cash flow positive result. The Company is confident that following the strong start to Q2 FY2023 and recent expansion into Alberta, Mernova will continue to achieve sales growth. Additional updates on new purchase orders and product listing updates with province partners will be made as developments materialise. Management commentary: CEO and Managing Director, Mr William Lay said: “Mernova continues to make very pleasing progress across Canada and the approval to enter Alberta highlights the ongoing product demand the Company is witnessing from provincial partners. “The group will shortly be active in eight of Canada’s ten provinces and we look forward to continuing to build strong brand awareness with key retailers and consumers to drive sales. We are confident that further sales will materialise during the quarter, which will lay a strong foundation for Group revenue
- Forums
- ASX - By Stock
- Ann: Halucenex Phase II Clinical Trial Update
Canada exponentially huge, cash flow positive & growing. Many...
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity